Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001437749-26-002575 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 30, 2026 |
| Document Date | Jan 28, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
170,833
Total Value
$67,437.75
P&L
+inf% (+$1,953,600.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CMO & Head of Development | Class A Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 3,611 | $4.50 | $16,249.50 | 3,611 | Direct | โ | View Details | |
CMO & Head of Development | Class A Common Stock | โ | Jan 28, 2026 | Sale | 2,800 | $14.09 | $39,441.08 | 811 | Direct | โ | View Details | |
CMO & Head of Development | Class A Common Stock | โ | Jan 28, 2026 | Sale | 811 | $14.48 | $11,747.17 | 0 | Direct | โ | View Details | |
CMO & Head of Development | Stock Option (right to buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 3,611 | $0.00 | $0.00 | 252,778 | Direct | โ | View Details | |
CMO & Head of Development | Stock Option (right to buy) | Derivative | Jan 30, 2026 | Grant/Award | 160,000 | $0.00 | $0.00 | 160,000 | Direct | โ | View Details |